Founded in 2006 and based in Ann Arbor, Michigan, Meditrina Pharmaceuticals focuses on identifying and repurposing already marketed therapies and product candidates to address unmet medical needs in women's health. Their initial focus is on gynecologic and aromatase-mediated conditions such as endometriosis and uterine fibroids, which affect millions of women each year. With a mission to improve women's health, the company is dedicated to developing innovative therapies for these overlooked therapeutic areas.